What does CUSIP 690469101 represent in this 13F holders report?

CUSIP 690469101 is the security identifier for OVID - Ovid Therapeutics Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held OVID - Ovid Therapeutics Inc. - Common Stock in Q1 2019?

47 institutional investors reported OVID - Ovid Therapeutics Inc. - Common Stock for Q1 2019. Use the holders table for investor-level position and value details.

Ovid Therapeutics Inc. - Common Stock (OVID)

CUSIP: 690469101

Q1 2019 13F Holders as of 31 Mar 2019

Security type / class: Equity / Common Stock
Total 13F shares: 12,276,773
Total 13F value: $21,734,954
Share change: +5,188,938
SEC-reported price per share: $1.77
Number of holders: 47
Value change: +$9,093,088
Number of buys: 29
Number of sells: 12
Shares outstanding: 186,597,793

Security key

690469101

Report period

Q1 2019

Institutions

Top holders

OVID full security history Ownership snapshot Full 13F holder table Ovid Therapeutics Inc. SEC filings Ovid Therapeutics Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of OVID - Ovid Therapeutics Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

ARMISTICE CAPITAL, LLC

Disclosed value leader

ARMISTICE CAPITAL, LLC

Comparable rows

15/15

Latest evidence

31 Dec 2018

13F Lead comparable stake: 0.86% Showing 1-6 of 15 holder rows.

Quick read

ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 0.86%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens ARMISTICE CAPITAL, LLC's linked filing trail.

Comparable ownership Top 5

ARMISTICE CAPITAL, LLC 0.86%

BlackRock Finance, Inc. 0.76%

COWEN INC. 0.46%

Redmile Group, LLC 0.4%

Tekla Capital Management LLC 0.27%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
ARMISTICE CAPITAL, LLC	13F Company 13F	0.86%	$3,872,000 1,600,000 shares	—	31 Dec 2018
BlackRock Finance, Inc.	13F Company 13F	0.76%	$3,424,000 1,414,696 shares	—	31 Dec 2018
COWEN INC.	13F Company 13F	0.46%	$2,060,000 851,414 shares	—	31 Dec 2018
Redmile Group, LLC	13F Company 13F	0.4%	$1,785,000 737,550 shares	—	31 Dec 2018
Tekla Capital Management LLC	13F Company 13F	0.27%	$1,203,000 496,977 shares	—	31 Dec 2018
VANGUARD GROUP INC	13F Company 13F	0.16%	$708,000 292,260 shares	—	31 Dec 2018

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2019

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

12,276,773

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2019 vs Q1 2019 Across Filers

Q1 2019 holders

Holder diff

Investor	Q1 2019 Shares	Q1 2019 Shares	Share Diff	Share Chg %	Q1 2019 value	Q1 2019 value	Value change	Value Chg %